1-Methyl-5-phenyl-1,3-dihydro-2H-benzo[e][1,4]diazepin-2-o
95%
- Product Code: 82215
CAS:
3034-65-9
| Molecular Weight: | 250.30 g./mol | Molecular Formula: | C₁₆H₁₄N₂O |
|---|---|---|---|
| EC Number: | MDL Number: | MFCD01314158 | |
| Melting Point: | 153 °C | Boiling Point: | 452.3±45.0 °C(Predicted) |
| Density: | 1.15±0.1 g/cm3(Predicted) | Storage Condition: | 2-8°C |
Product Description:
This compound is primarily utilized in the field of medicinal chemistry due to its structural similarity to benzodiazepines, which are known for their psychoactive properties. It is often studied for its potential effects on the central nervous system, particularly in the development of anxiolytic, sedative, or anticonvulsant drugs. Researchers explore its interactions with GABA receptors, which play a crucial role in regulating neuronal excitability. Additionally, it may serve as a key intermediate in the synthesis of more complex pharmaceutical compounds targeting neurological disorders. Its unique structure also makes it a candidate for investigating structure-activity relationships in drug design.
Sizes / Availability / Pricing:
| Size (g) | Availability | Price | Quantity |
|---|---|---|---|
| 0.100 | 10-20 days | ฿5,913.00 |
+
-
|
| 0.250 | 10-20 days | ฿10,755.00 |
+
-
|
| 1.000 | 10-20 days | ฿25,200.00 |
+
-
|
1-Methyl-5-phenyl-1,3-dihydro-2H-benzo[e][1,4]diazepin-2-o
This compound is primarily utilized in the field of medicinal chemistry due to its structural similarity to benzodiazepines, which are known for their psychoactive properties. It is often studied for its potential effects on the central nervous system, particularly in the development of anxiolytic, sedative, or anticonvulsant drugs. Researchers explore its interactions with GABA receptors, which play a crucial role in regulating neuronal excitability. Additionally, it may serve as a key intermediate in the synthesis of more complex pharmaceutical compounds targeting neurological disorders. Its unique structure also makes it a candidate for investigating structure-activity relationships in drug design.
| Mechanism | - |
| Appearance | - |
| Longevity | - |
| Strength | - |
| Storage | - |
| Shelf Life | - |
| Allergen(s) | - |
| Dosage (Range) | - |
| Recommended Dosage | - |
| Dosage (Per Day) | - |
| Recommended Dosage (Per Day) | - |
| Mix Method | - |
| Heat Resistance | - |
| Stable in pH range | - |
| Solubility | - |
| Product Types | - |
| INCI | - |
Cart
No products
Subtotal:
฿0.00
฿0.00
Total :